No one is a stranger to Covid-19 and how it has affected the universe over the last year and many attempts such as vaccines and other treatments have been made to curb and cure the biggest enemy the world has seen in the last many decades. Treatments and cures have had varying degrees of success to date and governments are spending money on a Swiss Army knife of solutions in the fight against the pandemic.
Amongst one of the various tools used to mitigate Covid-19, there is new testing technology by the ISBRG Corp. which has come up with a solution for testing Covid-19 through their new “SpotLight-19©” technology.
The SpotLight-19© is a fast, inexpensive, and reusable testing tool that has been designed to ensure safe workplace environments. The mission behind SpotLight-19 technology platform is to monitor health, which also includes the state of infection in Covid-19. SpotLight-19© uses state of the art technology in its operations including machine learning.
The SpotLight-19© technology detects Covid-19 in less than 20 seconds. It is only expected to charge $1 per test which is quite minimal. This means the new SpotLight-19© technology will be a fast and effective way for testing Covid-19, which will not only help in reducing the cases of the disease but curb it quickly for it is fast and inexpensive. The purpose behind ISBRG Corp’s SpotLight-19© technology is to accommodate large numbers of people to test them for Covid-19 without unnecessary delays and environmental damage.
SpotLight-19© technology is intended to be used in high volume venues including airports, border crossings, schools and campuses, government buildings, public buildings, hospitals, private businesses, and entertainment complexes. It will also be used to help economies surge out Covid-19 and be used for the reopening of global economies as well.
With the market size of global Covid-19 diagnostics to expand at a compounded annual growth rate of 3.1% from 2021 to 2027, SpotLight-19© technology may be in very high demand in the next few months. It is different than most of the current diagnostic technologies commercially available today because of its operational speed and low price point.
The ISBRG Corp.
The name behind the forthcoming SpotLight-19© technology is ISBRG Corp. The ISBRG Corp. is a data analytics company which has designed and developed the ‘SpotLight-19© technology platform’ that forms quick and concise health care data, non-invasively, and in seconds, at a small incremental cost per test.
ISBRG Corp. incorporates advanced technology in its operations and has come up with the SpotLight-19© in response to the Coronavirus. At the moment, ISBRG Corp. is taking on trials to look at the effectiveness of the technology.
ISBRG group is headquartered in Mississauga, Ontario. Their latest SpotLight-19© technology platform, which is based on an incredibly unique model, involves a non-intrusive scan of an individual’s finger with a harmless beam of light to detect Covid-19. Moreover, their model is also designed for understanding the state of Covid-19 infection as well, by providing instant confirmation of Covid-19 infection (if a person has it,) in less than a minute.
ISBRG group’s massive effort leverages advancements in AI and optics to provide a solution for Covid-19 that hasn’t been seen so far.
ISBRG group adopts technology in its platform that can be used to treat viral infection (by detecting unique infections including Covid—19), drug impairment, athletic fitness, nutritional health, healthy aging and adolescent health.
Who Is Behind ISBRG Corp?
At the forefront of ISBRG Corp is Duncan MacIntyre as its Founder & CEO. Mr. MacIntyre has held several executive roles including Vice-President General Manager at Monsanto Company, and has also co-authored more than 25 spectroscopy related diagnostic patents. Mr. McIntyre received a Bachelor Of Science at St. Francis Xavier University and a Master of Business Administration from St. Mary’s University in Halifax, Nova Scotia.
Allan MacDougall sits as its Vice President Corporate, a former Director General Global Operations at Canadian Security Intelligence Service also known as (CSIS). As Chief Technology Officer is Jordan MacIntyre who served as a lead developer for drone software with NXP Semiconductors and has most recently co-authored several ISBRG patent filings. Other members of the ISBRG Corp. includes Dr. Rae Lake as its Medical Director, Angus Galloway as its Director of Artificial Intelligence, Dr. Monica Williamson as their Director, Research, Austin MacIntyre as their Vice President Operations and Communications. Austin MacIntyre was the author and winner of a THC detection challenge which was sponsored by the Ontario Government.
In addition, ISBRG Corp boasts an impressive advisory board Allan MacDougall as their Chairmen, former NASA/CSA Astronaut Col. Chris Hadfield. In April of 2020, Col. Chris Hadfield was featured in the Sarnia Journal where Col. Hadfield discusses his recent work with ISBRG Corp. Col. Hadfield stated “We’re trying to find a rapid way to diagnose whether someone has been exposed or not, where you could lay your finger on top of a light sensor and within 15 seconds, by doing a spectroscopic analysis of your blood, it could say whether your body is reacting to COVID or not”.
An interesting note on ISBRG’s advisors is William Sutherland. Vice-President of Business Development at Kilmer Group. Mr. Sutherland worked at the Global Investment Banking division at RBC Capital Markets and is currently driven on the creation of a new platform for investment opportunities at Kilmer Group. Kilmer Group is headed then none other Lawrence Tanenbaum, a private equity investor and Chairman & CEO of Kilmer Van Nostrand Co. Limited, Kilmer Groups primary Holding company. Kilmer Group has significant and very notable investments including Coca-Cola Bottling Limited and Maple Leaf Sports & Entertainment! Mr. Sutherland is a very interesting advisor to have on ISBRG Corp. and we’ll be interested to know if there is a bigger connection to Kilmer Group. Other notable advisors include former Global Executive Vice President of Amgen (NYSE: AMGN) Michael Kelly, Order of Canada and Order of Nova Scotia HL Col. R. Irene d’Entremont and former President and CEO of American Eagle Airline Mr. Peter Bowler.
On February 18th 2021, Universal PropTech (TSX-V: UPI) became a strategic investor in ISBRG Corp. The CEO of UPI Chris Hazelton stated, “We have been committed to ensuring safe and healthy workspaces for our clients and facilitating the return of workers to workspaces in the face of the pandemic, and SpotLight-19© as a rapid, inexpensive and reusable testing platform to ensure safe work environments, could be a catalyst to opening global economies”. Although UPI’s recent investment is fairly early to tell, the current management team along with its novel technology could prove to be a game changer investment for Universal PropTech!
Furthermore, once the trials and assorted government procedures regarding SpotLight-19© are done, SpotLight-19© will be marketed aggressively along all governmental and educational providers throughout Canada.
ISBRG Corp’s latest effort to develop a technology that can help in reducing Covid-19 cases is quite impressive. The group is large and has many talented people running the show which adds to its legitimacy. ISBRG’s inexpensive solution is expected to assist in the fight Covid-19 by reducing the number of cases by recognition (of Covid-19 and its infection as well) in order to mitigate the spread of Covid-19 and bring back people and economies after the pandemic.
Forward Looking Statements: This article may contain "forward-looking information" (as defined in applicable Canadian securities legislation) that is based on expectations, estimates and projections as of the date of the content is published on this website. Wherever possible, words such as "anticipate", "believe", "expects", "intend" and similar expressions have been used to identify these forward- looking statements. Information in this article has been furnished for your information only, is accurate at the time of posting, and may be superseded by more current information. Except as required by law, we do not undertake any obligation to update the information, whether as a result of new information, future events or otherwise. This article should not be considered as personal financial advice. Full Disclosure: Universal PropTech Inc. is a client of The parent company of EquityInsight.ca. Directors of the parent company of Equity Insight may buy, hold or sell the securities before during or after this publication.